South Wales, Dec. 26 -- United Kingdom Intellectual Property Office (UKIPO) has registered trademark "SK5" on Dec. 5. The details about the trademark application no. UK00004306298 published in the journal no. 2025/051 (Dec. 19).
With Appleyard Lees IP LLP as representative, Skyhawk Therapeutics, Inc. filed the trademark application for the below mentioned good(s)/service(s).
Class 5 : Pharmaceuticals, namely, small molecule therapeutic preparations for the correction of RNA expression and alteration of RNA translation, used in the treatment of Huntington's Disease.
The original document can be viewed at: http://www.ipo.gov.uk/cgi-bin/redirect.cgi?type=tmj&link=6¶m1=UK00004306298
Disclaimer: Curated by HT Syndication.
